Pfizer, Inc. (NYSE:PFE)
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Snugglah
(24.68)
Submitted: 5/7/2013 12:20:49 PM :
Start Price:
$28.55
PFE Score:
-0.48
new drugs & baby boomers - I think this is a winning combination.
Recs
Recs
DrGoldin
(98.14)
Submitted: 4/23/2013 10:59:17 PM :
Start Price:
$30.82
PFE Score:
-10.53
I'm seriously late to this party, but the forward p/e is STILL less than 14.
Recs
itsthedudeguy
(30.69)
Submitted: 4/9/2013 10:51:44 AM :
Start Price:
$28.86
PFE Score:
-5.22
div + growth = buy
Recs
andrewstrate
(72.99)
Submitted: 4/5/2013 2:12:45 AM :
Start Price:
$28.72
PFE Score:
-6.27
Go Kalamazoo they are creating bigger dicks everyday! Those people are always seeming to win.
Recs
robotclo
(58.39)
Submitted: 3/19/2013 2:12:12 AM :
Start Price:
$27.87
PFE Score:
-2.24
Good year for health care
Recs
DrMag
(45.45)
Submitted: 3/14/2013 2:15:15 PM :
Start Price:
$27.75
PFE Score:
-1.01
Very undervalued; new products just reaching the stage to come to market.
Recs
cyruswindsong
(< 20)
Submitted: 3/12/2013 10:09:31 PM :
Start Price:
$27.69
PFE Score:
-1.32
becuse of the rise of bad health issues and obeisity in the world. diabetis is on the rise. Pfizer is searching for better meds. for the masses. so now they give us "Afrezza" a new inhaleable insulin for diabetis.....a promising new med.
Recs
djohn1969
(< 20)
Submitted: 3/12/2013 1:53:19 AM :
Start Price:
$19.89
PFE Score:
+24.48
Hmmmm. I don't hear so much of all that "pipeline cliff" noise pundits were talking about Pfizer a couple years ago. A strong pipeline and big deals mean Pfizer will continue to say pffffft to the silly pipeline cliff talk.
Recs
jalalaram333
(< 20)
Submitted: 3/11/2013 8:02:07 PM :
Start Price:
$28.00
PFE Score:
-2.30
Pfizer managed Lipitor's LOE well and learend to diversify on multiple successful medicines. It is constantly reshuffling and reinventing its management and portfolio. Publicly known data show upwards activity for new drug indications and new drugs targeted for approval soon.
Recs
Recs
bsmiling22
(< 20)
Submitted: 2/25/2013 7:17:56 PM :
Start Price:
$26.67
PFE Score:
-1.52
great co lots of pipeline
Recs
JorgeAura
(23.02)
Submitted: 2/2/2013 4:43:28 PM :
Start Price:
$27.14
PFE Score:
+2.99
Dowjones in maximums.
Recs
bclan13
(99.31)
Submitted: 1/24/2013 12:50:09 AM :
Start Price:
$26.42
PFE Score:
+0.91
I'm not sure what earnings growth is expected but I don't understand why there would be. I understand the dividend but when bond yields rise pharma sector is going to get knocked in the mouth.
Recs
john603
(41.48)
Submitted: 1/9/2013 12:45:39 AM :
Start Price:
$25.78
PFE Score:
-0.68
Great yield good chart pattern Chamer chart talk
Recs
judysway
(39.03)
Submitted: 1/8/2013 8:02:21 AM :
Start Price:
$25.56
PFE Score:
+0.15
Pfizer is helping to fund research for Organovo, I believe their connection will be profiting both companies.
Recs
befoolin
(< 20)
Submitted: 12/12/2012 11:25:00 AM :
Start Price:
$24.50
PFE Score:
+1.07
My favorite drug...play
Recs
6sigmaford
(26.72)
Submitted: 12/12/2012 8:49:02 AM :
Start Price:
$25.19
PFE Score:
+0.49
They will likely have another breakout drug very soon.
Recs
RentonComments
(< 20)
Submitted: 11/16/2012 12:46:11 PM :
Start Price:
$23.37
PFE Score:
+3.03
Solid yield, very good market sector going forward.
Recs
BHead5531
(52.33)
Submitted: 9/20/2012 1:30:02 PM :
Start Price:
$23.75
PFE Score:
+9.37
Cramer loves it...curious to see what happens
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 985 : 1 2 3 4 5 6 7 8 9 10 Next »